Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-11-05 Sale |
2021-11-09 4:46 pm |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
220,362 | $6.2533 | $1,377,986 | 86,438 (Indirect) |
View |
2021-11-03 Sale |
2021-11-05 4:13 pm |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
202,200 | $6.4911 | $1,312,501 | 97,500 (Indirect) |
View |
2021-10-08 Sale |
2021-10-13 07:57 am |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
165,100 | $5.0313 | $830,670 | 117,100 (Indirect) |
View |
2021-08-20 Purchase |
2021-08-20 4:08 pm |
Eton Pharmaceuticals Inc. | ETON | Troutman William Wilson CFO, Treasurer & Secretary |
5,000 | $4.43 | $22,150 | 23,027 (Direct) |
View |
2021-08-20 Purchase |
2021-08-20 4:06 pm |
Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO |
10,000 | $4.32 | $43,200 | 1,054,940 (Indirect Direct) |
View |
2021-08-04 Sale |
2021-08-06 9:53 pm |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
604,500 | $5.8283 | $3,523,187 | 117,100 (Indirect) |
View |
2021-06-15 Sale(A) |
2021-06-21 06:05 am |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
105,000 | $8.07 | $847,350 | 141,600 (Indirect) |
View |
2021-06-15 Sale |
2021-06-17 4:39 pm |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
105,000 | $8.07 | $847,350 | 141,600 (Indirect) |
View |
2021-06-03 Purchase |
2021-06-03 12:11 pm |
Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO |
5,000 | $5.96 | $29,800 | 1,054,940 (Indirect Direct) |
View |
2021-05-25 Sale |
2021-05-27 7:34 pm |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
242,300 | $8.5205 | $2,064,511 | 145,600 (Indirect) |
View |
2021-04-12 Sale |
2021-04-12 7:55 pm |
Eton Pharmaceuticals Inc. | ETON | HARROW HEALTH INC. 10% Owner |
1,518,000 | $7 | $10,626,000 | 1,982,000 (Direct) |
View |
2020-10-16 Purchase |
2020-10-16 9:30 pm |
Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner |
400,000 | $7 | $2,800,000 | 155,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-05-03 Option Award |
2021-05-05 4:16 pm |
N/A 2031-05-03 |
Eton Pharmaceuticals Inc. | ETON | CASAMENTO CHARLES J Director |
19,655 | $0 | 59,555 (Direct) |
View |
2021-05-03 Option Award |
2021-05-05 4:16 pm |
N/A 2031-05-03 |
Eton Pharmaceuticals Inc. | ETON | BRYNJELSEN SEAN President & CEO |
245,000 | $0 | 1,185,000 (Direct) |
View |
2021-05-03 Option Award |
2021-05-05 4:15 pm |
N/A 2031-05-03 |
Eton Pharmaceuticals Inc. | ETON | RIEDEL NORBERT G Director |
19,655 | $0 | 59,555 (Direct) |
View |
2021-05-03 Option Award |
2021-05-05 4:15 pm |
N/A 2031-05-03 |
Eton Pharmaceuticals Inc. | ETON | Troutman William Wilson CFO and Secretary |
125,000 | $0 | 656,200 (Direct) |
View |
2021-05-03 Option Award |
2021-05-05 4:15 pm |
N/A 2031-05-03 |
Eton Pharmaceuticals Inc. | ETON | Adams Jennifer McKie Director |
28,133 | $0 | 28,133 (Direct) |
View |
2021-05-03 Option Award |
2021-05-05 4:15 pm |
N/A 2031-05-03 |
Eton Pharmaceuticals Inc. | ETON | MAIER PAUL V Director |
19,655 | $0 | 59,555 (Direct) |
View |
2020-03-19 Ownership |
2021-02-16 08:59 am |
N/A N/A |
Eton Pharmaceuticals Inc. | ETON | CASAMENTO CHARLES J Director |
3,500 | $0 | 68,420 (Direct) |
View |